| mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.0079 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
0.019 |
0.9 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.0059 |
0.9 |